FLOW CYTOMETRIC ANALYSIS AND CONFOCAL IMAGING OF ANTICANCER ALKYLAMINOANTHRAQUINONES AND THEIR N-OXIDES IN INTACT HUMAN-CELLS USING 647-NM KRYPTON LASER EXCITATION
Pj. Smith et al., FLOW CYTOMETRIC ANALYSIS AND CONFOCAL IMAGING OF ANTICANCER ALKYLAMINOANTHRAQUINONES AND THEIR N-OXIDES IN INTACT HUMAN-CELLS USING 647-NM KRYPTON LASER EXCITATION, Cytometry, 27(1), 1997, pp. 43-53
Flow cytometry and laser-scanning confocal fluorescence microscopy hav
e been used in the study of the pharmacodynamics, in single intact cel
ls, of two novel alkylaminoanthraquinones (AQ4 and AQ6), structurally
based upon the mid-red excitable but very weakly fluorescent anticance
r agent mitoxantrone, together with their respective N-oxide derivativ
es (AQ4NO and AQ6NO). The drug design rationale was that N-oxide modif
ications generates prodrug forms suitable for selective bioreductive-a
ctivation in hypoxic tumor cells. DNA-binding ranked in the order of m
itoxantrone >AQ6 >AQ4 >AQ6NO >>AQ4NO. Using both cytometric methods a
similar ranking was found for whole cell and nuclear location in human
transformed fibroblasts. However, AQ6 showed enhanced nuclear uptake
compared with mitoxantrone, in keeping with its greater capacity to in
hibit DNA synthesis. Partial charge neutralisation by N-oxide derivati
zation resulted in loss of DNA synthesis inhibition but retention of t
he ability to accumulate in the cytosol, an important property for pro
drug development. We conclude that both flow cytometry and confocal im
aging revealed biologically significant differences between analogues
for subcellular distribution and retention properties, The study demon
strates the potential for these complementary 647-nm krypton laser lin
e-based fluorometric methods to provide relevant structure-activity in
formation in anthraquinone drug-design programmes. (C) 1997 Wiley-Liss
, Inc.